» Articles » PMID: 29207840

Evaluation of the Efficacy of G32 (Commercially Available Ayurvedic Preparation) in Reducing Halitosis - A Randomized Controlled Trial

Overview
Specialty General Medicine
Date 2017 Dec 7
PMID 29207840
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Oral malodour is a social malady affecting people of all the age groups. Effective management of oral malodour is the key to improve the quality of life of such people.

Aim: To evaluate the effectiveness of ayurvedic medication, G32 in controlling oral malodour and comparing the effects with Chlorhexidine (CHX).

Materials And Methods: This was a single blind randomized controlled trial with parallel study design conducted at a hospital in the city of Udupi in Southern India. A total of 40 patients suffering with oral malodour, aged 17-35 years, were included in this trial. After inclusion into the study, the subjects were examined twice, with a one-week interval between both examinations. Volatile Sulphur Compounds (VSCs), gingival, plaque and tongue coating scores were assessed at both examinations. Subjects were randomly allocated to G32 group - ayurvedic formulation (intervention group) and CHX group (control group), and were provided with the respective formulations enough to be used twice daily for a period of one week. The difference between the mean scores of VSCs, plaque, and gingivitis and tongue coating were compared within the intervention and control groups, respectively, using paired t-test.

Results: Both test and control groups showed a significant reduction in VSCs, plaque and gingivitis levels. The percentage reductions in VSCs, plaque and gingivitis were found to be similar among the two groups. There was no significant difference between the preintervention and postintervention scores in both the groups.

Conclusion: G32, an ayurvedic medication, can be an effective tool to deal with oral malodour.

Citing Articles

Effect of using different materials and restorative techniques on cuspal deflection and microleakage in endodontically treated teeth.

Sari C, Bala O, Akgul S, Alp C BMC Oral Health. 2025; 25(1):302.

PMID: 40000998 PMC: 11853680. DOI: 10.1186/s12903-025-05693-0.


Interventions for managing halitosis.

Nagraj S, Eachempati P, Uma E, Singh V, Ismail N, Varghese E Cochrane Database Syst Rev. 2019; 12:CD012213.

PMID: 31825092 PMC: 6905014. DOI: 10.1002/14651858.CD012213.pub2.


Efficacy of chlorhexidine, hydrogen peroxide and tulsi extract mouthwash in reducing halitosis using spectrophotometric analysis: A randomized controlled trial.

Sharma K, Acharya S, Verma E, Singhal D, Singla N J Clin Exp Dent. 2019; 11(5):e457-e463.

PMID: 31275519 PMC: 6599699. DOI: 10.4317/jced.55523.


Photodynamic therapy with Bixa orellana extract and LED for the reduction of halitosis: study protocol for a randomized, microbiological and clinical trial.

Goncalves M, Costa da Mota A, Deana A, Guedes G, de Souza Cavalcante L, Prates R Trials. 2018; 19(1):590.

PMID: 30373650 PMC: 6206672. DOI: 10.1186/s13063-018-2913-z.

References
1.
Yaegaki K, Coil J . Examination, classification, and treatment of halitosis; clinical perspectives. J Can Dent Assoc. 2000; 66(5):257-61. View

2.
Charles C, Mostler K, Bartels L, Mankodi S . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol. 2004; 31(10):878-84. DOI: 10.1111/j.1600-051X.2004.00578.x. View

3.
Loe H, SILNESS J . PERIODONTAL DISEASE IN PREGNANCY. I. PREVALENCE AND SEVERITY. Acta Odontol Scand. 1963; 21:533-51. DOI: 10.3109/00016356309011240. View

4.
Cortelli J, Barbosa M, Westphal M . Halitosis: a review of associated factors and therapeutic approach. Braz Oral Res. 2009; 22 Suppl 1:44-54. DOI: 10.1590/s1806-83242008000500007. View

5.
Roldan S, Herrera D, Santa-Cruz I, OConnor A, Gonzalez I, Sanz M . Comparative effects of different chlorhexidine mouth-rinse formulations on volatile sulphur compounds and salivary bacterial counts. J Clin Periodontol. 2004; 31(12):1128-34. DOI: 10.1111/j.1600-051X.2004.00621.x. View